Cargando…

Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation

The metabolism of vandetanib, a tyrosine kinase inhibitor used for treatment of symptomatic/progressive medullary thyroid cancer, was studied using human hepatic microsomes, recombinant cytochromes P450 (CYPs) and flavin-containing monooxygenases (FMOs). The role of CYPs and FMOs in the microsomal m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indra, Radek, Pompach, Petr, Martínek, Václav, Takácsová, Paulína, Vavrová, Katarína, Heger, Zbyněk, Adam, Vojtěch, Eckschlager, Tomáš, Kopečková, Kateřina, Arlt, Volker Manfred, Stiborová, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679423/ https://www.ncbi.nlm.nih.gov/pubmed/31295928 http://dx.doi.org/10.3390/ijms20143392

Ejemplares similares

Cytochrome b(5) plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine
por: Stiborová, Marie, et al.
Publicado: (2017)

Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib
por: Jáklová, Kateřina, et al.
Publicado: (2021)

Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b(5) Activity
por: Indra, Radek, et al.
Publicado: (2020)

Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches
por: Martínek, Václav, et al.
Publicado: (2017)

The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers
por: Šulc, Miroslav, et al.
Publicado: (2016)

A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches
por: Stiborová, Marie, et al.
Publicado: (2015)

NADH:Cytochrome b(5) Reductase and Cytochrome b(5) Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene
por: Stiborová, Marie, et al.
Publicado: (2016)

Correction to NADH:Cytochrome b(5) Reductase and Cytochrome b(5) Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene
por: Stiborová, Marie, et al.
Publicado: (2016)

Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[a]pyrene in prokaryotic and eukaryotic expression systems
por: Stiborová, Marie, et al.
Publicado: (2017)

Application of hepatic cytochrome b(5)/P450 reductase null (HBRN) mice to study the role of cytochrome b(5) in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
por: Reed, Lindsay, et al.
Publicado: (2019)

Induced expression of microsomal cytochrome b(5) determined at mRNA and protein levels in rats exposed to ellipticine, benzo[a]pyrene, and 1-phenylazo-2-naphthol (Sudan I)
por: Stiborová, Marie, et al.
Publicado: (2016)

Oxidation of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxy-naphthalene (Sudan I) by cytochromes P450 and peroxidases: a comparative study
por: Stiborová, Marie, et al.
Publicado: (2009)

Cytochrome b(5) impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b(5)/P450 reductase null (HBRN) mice
por: Reed, Lindsay, et al.
Publicado: (2018)

Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1
por: Milichovský, Jan, et al.
Publicado: (2016)

NADPH- and NADH-dependent metabolism of and DNA adduct formation by benzo[a]pyrene catalyzed with rat hepatic microsomes and cytochrome P450 1A1
por: Stiborová, Marie, et al.
Publicado: (2016)

Rat cytochromes P450 oxidize 3-aminobenzanthrone, a human metabolite of the carcinogenic environmental pollutant 3-nitrobenzanthrone
por: Mizerovská, Jana, et al.
Publicado: (2008)

Differentiation‐associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic‐metabolizing activity of “luminal” muscle‐invasive bladder cancers
por: Baker, Simon C., et al.
Publicado: (2018)

The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes
por: Stiborová, Marie, et al.
Publicado: (2014)

Apoferritin as an ubiquitous nanocarrier with excellent shelf life
por: Dostalova, Simona, et al.
Publicado: (2017)

Cytochrome P450-mediated metabolism of N-(2-methoxyphenyl)-hydroxylamine, a human metabolite of the environmental pollutants and carcinogens o-anisidine and o-nitroanisole
por: Naiman, Karel, et al.
Publicado: (2008)

Oxidation of carcinogenic 2-nitroanisole by rat cytochromes P450 – similarity between human and rat enzymes
por: Svobodová, Martina, et al.
Publicado: (2008)

Optimalization of preparation of apo-cytochrome b(5) utilizing apo-myoglobin
por: Mrázová, Barbora, et al.
Publicado: (2008)

Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine
por: Mrízová, Iveta, et al.
Publicado: (2016)

Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells
por: Hřebačková, Jana, et al.
Publicado: (2009)

Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response
por: Hlaváč, Viktor, et al.
Publicado: (2021)

Sarcosine as a Potential Prostate Cancer Biomarker—A Review
por: Cernei, Natalia, et al.
Publicado: (2013)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)

The Role of Metallothionein in Oxidative Stress
por: Ruttkay-Nedecky, Branislav, et al.
Publicado: (2013)

Experimental approaches to evaluate activities of cytochromes P450 3A
por: Bořek-Dohalská, Lucie, et al.
Publicado: (2008)

Vandetanib
por: Vozniak, J. Michael, et al.
Publicado: (2012)

Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
por: Skubalova, Zuzana, et al.
Publicado: (2021)

Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo
por: Dračínská, Helena, et al.
Publicado: (2016)

The effects of selected flavonoids on cytochromes P450 in rat liver and small intestine
por: Křížková, Jitka, et al.
Publicado: (2009)

Mechanisms of Enzyme-Catalyzed Reduction of Two Carcinogenic Nitro-Aromatics, 3-Nitrobenzanthrone and Aristolochic Acid I: Experimental and Theoretical Approaches
por: Stiborová, Marie, et al.
Publicado: (2014)

Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes
por: Heger, Zbynek, et al.
Publicado: (2016)

Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer
por: Heger, Zbynek, et al.
Publicado: (2016)

Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin
por: Dostalova, Simona, et al.
Publicado: (2018)

Water Oxidation by a Cytochrome P450: Mechanism and Function of the Reaction
por: Prasad, Brinda, et al.
Publicado: (2013)

Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2
por: Aimová, Dagmar, et al.
Publicado: (2008)

Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin
por: Merlos Rodrigo, Miguel Angel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b9d8qcfa303oq5f1okqv8k0vnn